ADP-ribosylation is a post-translational modification of proteins that comprises the transfer of the ADP-ribose moiety from NAD + to specific amino acid residues on substrate proteins or to ADP-ribose itself. It is catalyzed by ADP-ribosyltransferases, a family of currently 22 human proteins that all possess an ADPribosyltransferase catalytic domain. ADP-ribosylation is a reversible modification that can be hydrolyzed by ADPribosyl hydrolases. In order to define the functional role of cellular ADP-ribosylation and the functional contribution of distinct ARTD family members, it is necessary to identify all ADP-ribosylated proteins, as well as their modified residues in the context of different cellular conditions and stresses. Here, we summarize the most recent progress in defining the cellular ADP-ribosylome and the efforts to detect ADP-ribose acceptor sites by enzymatic reactions and mass-spectrometry.
ABSTRACT
ADP-ribosylation is a post-translational modification of proteins that comprises the transfer of the ADP-ribose moiety from NAD + to specific amino acid residues on substrate proteins or to ADP-ribose itself. It is catalyzed by ADP-ribosyltransferases, a family of currently 22 human proteins that all possess an ADPribosyltransferase catalytic domain. ADP-ribosylation is a reversible modification that can be hydrolyzed by ADPribosyl hydrolases. In order to define the functional role of cellular ADP-ribosylation and the functional contribution of distinct ARTD family members, it is necessary to identify all ADP-ribosylated proteins, as well as their modified residues in the context of different cellular conditions and stresses. Here, we summarize the most recent progress in defining the cellular ADP-ribosylome and the efforts to detect ADP-ribose acceptor sites by enzymatic reactions and mass-spectrometry.
ADP-RIBOSYLATION
Until now, proteomic studies have identified more than 200 different post-translational modifications (PTMs), which add a high level of complexity to the proteome, generating over 1 million different proteins from approximately 20,000 protein-coding genes (1, 2) . PTMs allow the cell to adapt and cope with stress conditions such as environmental stimuli, pathogens or diseases. The beststudied PTMs are the covalent modification of amino acids with small chemical groups such as phosphate, acetate or methyl (3) . ADP-ribosylation is an ancient PTM that is conserved in all organisms from bacteria to humans, except in yeasts, and is catalyzed by ADP-ribosyltransferases (ARTs) (4) (5) (6) . ADP-ribosylation can be divided into two subtypes (7): mono-ADP-ribosylation, which defines a reaction where only one ADP-ribose group is transferred to the target protein amino acid (8) , and poly-ADPribosylation (PARylation), which involves the transfer and proteins that harbor a catalytic domain similar to the one found in PARP have been identified up to now (6) . Based on available amino acid sequences and crystal structures, the mammalian ARTs can be grouped into two groups that differ in their catalytic motif (6) . One group shares structural similarities with Cholera toxin and is therefore referred to as ADP-ribosyltransferase Cholera toxin-like (ARTC). Currently, human ARTCs comprise of five members (ARTC1-5), which are all located at the cell membrane facing the extracellular space (6) . The second group shares structural similarities to Diphtheria toxin and is therefore referred to as ADP-ribosyltransferase Diphtheria toxin-like (ARTD). Eighteen different human ARTD members (ARTD1-18, ARTD1 representing the initially identified PARP protein) are currently known and found in different cellular compartments. The ARTD family can further be subdivided based on differences in the amino acid sequence of the catalytic core domain. ARTDs that were proposed to synthesize PAR are characterized by the presence of the conserved amino acid triad H-Y-E, whereas mono-ADP-ribosyltransferases lack the glutamate residue in position 3 of the triad (6) . The members of the ARTD family are sub-divided into three different groups based on their biochemical properties: the family-founding enzyme ARTD1 (PARP1), as well as ARTD2 (PARP2), generate branched PAR and are representative of the first group. ARTD1 is the most abundant nuclear ARTD family member and accounts for approximately 90% of the PAR formation in a cell (30) , whereas ARTD2 is less abundant, less active and responsible for the majority of the remaining PAR formation in cells that lack ARTD1 (30, 31) . Although ARTD3 harbors the H-Y-E triad, its enzymatic property is still under debate. Both mono-and poly-ADPribosylation activity have been reported for ARTD3 (32, 33) , suggesting that beside the H-Y-E triad, other amino acids or specific conditions are most likely also important for PAR formation. A second group of enzymes consists of the telomere-associated ARTD5 and ARTD6 (Tankyrase1 and 2), which like ARTD1, 2 and 3 are also able to modify themselves as well as several target proteins (34, 35) . In contrast to the first group, ARTD5 and ARTD6 are oligo-ADPribosyltransferases, which synthesize linear ADP-ribose chains with a maximum length of 20 units (35) . The third group contains enzymes that lack the glutamate residue in the abovementioned triad motif, limiting them to be mono-ADPribosyltransferases, as shown for ARTD8 (PARP14) and ARTD10 (PARP10) (36) . Moreover, although all identified ARTD family members share a common catalytic domain, it is not clear whether all proteins are enzymatically active (6) . Recent studies provided evidence that ARTD9 and ARTD13 do not posses catalytic activity (36, 37) . For the other mono-ADP-ribosyltransferases of the ARTD family, a catalytic activity was postulated, but still lacks experimental validation (6) . Recent overexpression and knockdown studies of all intracellular ARTD family members in HeLa cells revealed that most ARTDs are localized in the cytoplasm, that the ratio of nuclear to cytoplasmic poly(ADP-ribose) varies throughout the cell cycle and that four phenotypic classes of ARTD functions exist (38) . These functions are related to the regulation of membrane structures, cell viability, cell division and influence the actin cytoskeleton.
READERS OF ADP-RIBOSYLATION
PTMs modulate the activity of target proteins either directly or indirectly by affecting complex formation with other proteins. An important concept in the realm of PTMs is thus the recognition and specific binding of a given modification by 'reader' proteins. In the case of ADP-ribosylation, a large number of PAR binding proteins is recruited to modification sites where they function in a modification-dependent manner (16, 39) . Therefore, noncovalent binding of reader proteins to ADP-ribosylated targets is an important mechanism for mediating many of the regulatory functions of ADP-ribosylation (40) . PARbinding domains that have been described so far are the PAR-binding motifs (PBMs), macrodomains, PAR-binding zinc-fingers (PBZs) and the WWE domains (23, 39, 41).
PAR-binding motifs (PBMs)
The first motif described to interact with PAR was the PBM motif found in various proteins of the DNA damage signaling network and in DNA repair factors (e.g., p53, XRCC1, MRE11, ATM, Ku70/86 and DNA-PK) (29, 42, 43 (23, 43) . The PBM non-covalently interacts with free PAR in vitro, which is postulated to act as a scaffold for the recruitment of different DNA-repair proteins or function as a signaling factor that is sensed by PBM domain-containing proteins. This mechanism has so far only been described in a purely biochemical system and needs to be further validated in vivo.
Macrodomains
The macrodomain consists of 130-160 amino acids and displays a mixed a/ß-fold that is conserved in over 300 currently known macrodomain-containing proteins from viruses and bacteria to humans (23, 44). The first human macrodomain was identified in the histone variant macroH2A (45) . Until now, ten genes encoding 14 different macrodomain-containing proteins, harboring one to three folds, have been predicted by sequence homology in humans (46, 47) . A subgroup comprised of human ARTD8, MacroD2, and viral SARS-CoV has been shown to efficiently bind to mono-ADP-ribosylated proteins (48) (49) (50) (51) . In contrast, PAR-binding has been observed for human macroH2A1.1 and the macrodomain of ARTD9, as well as for the viral SFV protein. A third group, able to bind both mono-ADP-ribose and PAR, contains human MacroD1, viral HEV, as well as archaeal Af1521 (49, 50, 52) . Since it has been suggested that macrodomains bind to the terminal ADP-ribose of PAR (last moiety of the chain), it is likely that the differences in the binding of mono-and/or poly-ADP-ribose are due to steric reasons.
The WWE domain
The WWE domain is a globular domain that is defined by two conserved tryptophans (W) and a glutamic acid (E) residue and is usually found as a single or double domain. So far, WWE domains have been identified in two protein families; the E3 ubiquitin ligases (e.g., RNF146, DELTEX1 or Trip12) and the ARTDs (ARTD8 and ARTD11-14) (6, 23, 53) . The fact that all WWE domaincontaining proteins interact with ADP-ribose and either have ubiquitination activity or are members of the ARTD family, suggests that both mechanisms are tightly linked with and influence each other. For example, ADPribosylation could be a signal or recruiting factor for E3 ubiquitin ligases, which subsequently mark proteins for degradation or influence their properties (54) . WWE domains have the ability to interact with iso-ADP-ribose within the PAR chain (53, 54) . Some WWE domains have mutations in their binding motif that abolish PAR binding, but might turn them into mono-ADP-ribose binders (54, 55) . Examples are the WWE domains of DDHD2 or ARTD8 and, depending on the study, also of ARTD11, which are believed to bind the terminal ADP-ribose as well as a mono-ADP-ribose modification.
The PAR-binding zinc finger (PBZ)
The PAR-binding zinc finger (PBZ) is a small unordered fold with a zinc-coordinated backbone that can interact with one or two ADP-ribose units in a PAR chain and the connecting pyrophosphate bond as well as with the a(1->2) O -glycosidic bond between the ADP-ribose moieties (23, 56, 57) . So far, PBZ domains have only been identified in a few DNA-damage response proteins, like aprataxin and PNK-like factor (APLF), or in checkpoint with forkhead-associated and ring finger domains (CHFR) (56, 57) . Both proteins are recruited to sites of DNA damage in a PBZ-and PAR-dependent manner. Misregulation of CHFR is implicated in tumor progression, most probably due to its function at the antephase checkpoint, which is malfunctioning upon loss of the PBZ domain (56, 58).
ADP-RIBOSE ACCEPTOR SITES
In the case of bacterial ARTs, the acceptor amino acids have been successfully mapped because most of these toxins modify only a single protein or a class of proteins at a single specific residue (26, 27) . Most sites have been identified indirectly via chemical protection of potential acceptors, Edman-degradation, thin layer chromatography or other chemical methods and have later been confirmed by site directed mutagenesis (59) (60) (61) . This led to the identification of several sites with the main acceptors being arginine, asparagine, diphtamide and cysteine (26) . More recently, a study using mass spectrometry has identified threonine 148 of actin and glutamine 61 and 63 of RhoA as ADP-ribose acceptors (62) .
Despite substantial efforts, the identification of the amino acids in mammalian proteins specifically modified by a distinct ARTD has not been possible so far. Over thirty years ago, mammalian ADP-ribose acceptor sites were primarily characterized based on the chemical properties and stability of the modification on ARTD1, core histones and linker histone H1 (63) (64) (65) . As the majority (over 70%) of the analyzed ADP-ribose modifications were sensitive to alkali and neutral NH 2 OH, but stable to acid, a carboxyester linkage was suggested (65) . A linkage with such chemical properties points to glutamate or aspartate residues as acceptors, which has been believed for many years without further validation. Figure 1 . ADP-ribose linkage types depend on the acceptor site. a) The protein-bound ADP-ribose moiety can be linked to the acceptor site via the C1, C2 or C3 atom. The linkage to arginine (R) residues was identified as C1, which may also be the case for lysines (K). However, for glutamate (E) and aspartate (D), no final evidence has been provided so far. b) The best-characterized ADP-ribose acceptors are the acidic residues aspartate and glutamate, as well as the basic residues arginine and lysine. While in the first case a carboxylate ester linkage is formed, the latter two residues lead to N-glycosidically-linked ADP-ribose.
The remaining 30% of the modifications were NH 2 OH-resistant and 15% were even alkaline resistant, clearly indicating that other linkages must exist (64) . Later, experiments with two ARTCs from avian erythrocytes suggested that the NH 2 OH-resistant and alkali-stable fraction represents an ADP-ribose-arginine linkage (65) (66) (67) . However, under certain conditions NH 2 OH treatment was also reported to release ADP-ribose from modified arginine residues (68) . Together, these early observations provide clear evidence that chemical stability is not a reliable criterion to distinguish between different ADP-ribose acceptors sites, calling for other approaches to discriminate between different acceptor sites. More recent work using site-directed mutagenesis studies of ARTD1 and ARTD2 have identified lysine residues as ADP-ribose acceptors (69) . In contrast, site-directed mutagenesis experiments with ARTD10 have identified glutamates as acceptors sites (36) . As these studies have relied on mutagenesis experiments that can potentially alter the protein structure and therefore introduce a bias, methods based on mass spectrometry are needed to unequivocally identify ADPribose acceptor sites (see 6.3).
Moreover, the linkages within PAR or between ADP-ribose and the acceptor residue can potentially be of different chemical nature and therefore exhibit different biochemical properties. The ribose 5-phosphate of ADPribose has three potential linkage acceptors, which are the OH-groups at the C1, C2 and C3 position (63) (Figure 1a ). Preliminary studies suggested an attachment at the C1 position in the case of modified glutamates, but these results only provided indicative, but not conclusive evidence (63) (Figure 1b) . In contrast, mono-ADPribosylation of arginines has been analyzed by NMR and could be identified as being C1 linked (70) (Figure 1b ). Furthermore, it was shown that the enzymatic reaction results in a ribosyl-guanidinium linkage in a conformation, which undergoes anomerization to a ß linkage in a 1:1 ratio under physiological conditions (70) . All these results illustrate the high complexity of ADP-ribosylation ( Figure  1 ). Furthermore, while research has focused on enzymatically-catalyzed ADP-ribosylation, nonenzymatically-mediated, yet still covalent ADPribosylation has also been described (71, 72) . ADP-ribose is a potent histone glycation and glycoxidation agent in vitro (71) . Glycation is the covalent binding of an ADPribose molecule through Schiff base formation to lysine residues, which is stable upon treatment with hydroxylamine. Incubation of ADP-ribose with histones H1, H2A, H2B, and H4 in vitro at pH 7.5 and 37°C over night resulted in the formation of ketoamines by Amadori rearrangement of the formed Schiff base (71, 73, 74) . In the case of an Amadori rearrangement the attached ADP-ribose would be linked via a C1 linkage (74) . Based on the long incubation time, which is substantially longer than common incubation times of ADP-ribosylation reactions, glycation only needs to be considered in biological systems, if very high concentrations of free ADP-ribose are generated from NAD + or PAR. The specific types of linkages have potentially far-reaching biological implications, since they may affect the removal of different modifications by ADPribosyl hydrolases.
REMOVAL OF ADP-RIBOSYLATION
ADP-ribosylation regulates many important biological processes and serves as a specific signal. However, for the functioning of a cell, it is not only important that the signal is synthesized (written) in a coordinated and specific manner, but it must also be recognized by readers (see section 4) and be removed (erased) in a timely manner. Indeed, synthesis and degradation of PAR is a highly dynamic process with a half-life of only a few minutes (75) . Identifying and studying the enzymes that degrade PAR and erase the ADP-ribose modifications is thus of central importance for our understanding of the dynamics and the cellular functions of ADP-ribosylation.
Degraders of poly-ADP-ribosylation
The enzymatic activities that degrade PAR to ADP-ribose are currently poorly understood. This is partly due to the difficulty to analyze the different ADP-ribose structures, especially the complex linear-and branched poly-ADP-ribose (Figure 2a) .
Poly-ADP-ribose glycohydrolase (PARG)
PARG is the best-studied PAR-degrading enzyme so far and is composed of at least five isoforms: A nuclear 110-111 kDa isoform, three cytoplasmic isoforms and a mitochondrial isoform (76, 77) . All of these isoforms result from alternative splicing or from translation reinitiation of a single gene locus (14, 78) . PARG is the enzyme responsible for the majority of the PAR-degrading activity in cells. It hydrolyses the 2'-1'' glycosidic riboseribose bonds of PAR into free ADP-ribose moieties ( Figure  2a ), which can function as second messenger in various compartments of the cell or can be recycled into ATP (14, 78) . Recent structural studies have elucidated the enzymatic reaction mechanism and have identified several moieties that are important for PAR-binding and hydrolysis (79, 80 (79) . Some studies have proposed that PARG exhibits an endoactivity besides the exo-glycohydrolase activity that is weak, however (81, 82) . In contrast, earlier product analysis experiments revealed that protein-bound PAR is mainly cleaved endoglycosidically into large fragments, which can subsequently be further processed by endo-and exo-glycosidic digestion into single ADP-riboses (83) . Recently, the catalytic center of PARG has been reported to have structural homology to macrodomains (79) . Due to steric hindrance, the protein-bound ADP-ribose was proposed to not be hydrolyzed by PARG, resulting in a mono-ADP-ribosylated protein (81).
ADP-ribosyl hydrolase 3 (ARH3)
ARH3, another enzyme structurally distinct from the PARG proteins, was also found to only degrade PAR (but not to reverse mono-ADP-ribosylation) and in a manner similar to PARG, although most PAR-hydrolyzing activity of the cell is assigned to PARG (84, 85) ( Figure  2a ). As there is no structural similarity between the catalytic domains of ARH3 and PARG, (85, 86) , the presence of two independent and different mechanisms of PAR degradation in human cells is likely and possibly also functionally relevant.
Nudix hydrolases
In humans, an additional family of enzymes capable of hydrolyzing ADP-ribose exists. In contrast to the above-mentioned enzymes, the nudix box-containing enzymes do not remove protein bound ADP-ribose or PAR, but hydrolyze the pyrophosphate bond within ADP-ribose, generating AMP and ribose 5-phosphate (87) . The nudix superfamily is conserved in all kingdoms of life and is defined by its characteristic 23 amino acid nudix box motif Gx 5 Ex 5 [UA]xREx 2 EExGU, where U is a hydrophobic amino acid (87, 88) . Nudix proteins are pyrophosphohydrolases, which act on a variety of substrates containing a nucleoside diphosphate linked to another moiety (87) . In humans, NUDT5 and NUDT9 were shown to act as ADP-ribose pyrophosphatases, but NUDT5 has other substrates in addition to ADP-ribose (89) (90) (91) . Both enzymes were suggested to protect proteins from nonenzymatic glycation by free ADP-ribose, by controlling the free ADP-ribose level in the cell. On the other hand, nudix proteins have also been shown to be inhibited by cytotoxic compounds (e.g., H 2 O 2 ), a process that leads to accumulation of free ADP-ribose in addition to the enhanced PAR formation under stress (91).
Erasers of mono-ADP-ribosylation
The bonds within the PAR chain are of a different chemical nature than the first linkage between the acceptor site on the modified protein and the ADP-ribose. Consequently, most, if not all enzymes that degrade PAR leave the protein-bound ADP-ribose unit unchanged. The removal of this last ADP-ribose from the acceptor amino acid is the final and rate-limiting step of the de-ADPribosylation reaction. The last decade of ADP-ribosylation research has made it clear that different amino acids can serve as ADP-ribose acceptors. The differences in the chemical nature of acceptor residues such as lysines or glutamates, for example, imply that the chemical linkage between the acceptor side chain and the first ADP-ribose moiety must be chemically different. For example, an acidic amino acid would result in an ester bond, while at basic amino acids the ADP-ribose is linked via a Nglycosidic linkage (Figure 2b ). Given these differences, one would anticipate that different classes of erasers exist that remove ADP-ribose modifications from distinct acceptor sites.
ADP-ribosyl hydrolase 1 (ARH1)
In the early nineties, a new hydrolase for mono-ADP-ribosylated arginine residues was purified and characterized (92) . It was identified as an ADPribosylarginine-specific hydrolase in vitro and represented the founding member of the family of ADPribosylhydrolases (ARHs). Later, two more members of this family were identified by in silico sequence analysis and accordingly named ARH2 and ARH3 (86) . Further studies revealed that ARH1 is indeed a mono-ADP-ribose hydrolase able to cleave ADP-ribose-arginine catalyzed by the bacterial cholera toxin (84) (Figure 2b ). In contrast, no evidence for an enzymatic activity of ARH2 could be found so far (84) . Until now, ARH1 is the only enzyme able to revert mono-ADP-ribose of a modified arginine residue, which may have derived from the action of ARTC family members (86, 93, 94) . However, since ARH1 and the ARTCs are not localized in the same cellular compartment, an as yet unidentified arginine-specific intracellular ART might synthesize the ARH1 substrate. Very little is known about the biological function of the ARH protein family in vivo, but loss of ARH1 renders mice more prone to tumor formation (95) , indicating that the balance between ADPribose synthesis and degradation is a critical mechanism for guaranteeing proper cellular functions and survival.
Macrodomain proteins
Interestingly, some macrodomain proteins also exhibit a catalytic function in addition to their ability to bind to ADP-ribose. Human MacroD1, MacroD2, orphan macrodomain C6orf130, as well as E.coli YmdB, are able to deacylate O -acetyl-ADP-ribose (OAADPr) (96, 97) . OAADPr is the product of a protein deacetylation reaction, catalyzed by the NAD + -dependent sirtuins (98) . Macrodomains deacylate OAADPr, thereby producing ADP-ribose and acetate (97) . Additional properties, which are poorly understood and investigated, include binding of OAADPr and poly(A) as well as ADPR-1''P phosphatase activity (46, 50) . Recently a new enzymatic mechanism of MacroD1, MacroD2, C6orf130 and Af1521 has been investigated, identifying these proteins as novel glutamatespecific mono-ADP-ribosyl hydrolases (68, 99) (Figure  2b ). It could be shown that macrodomain-containing proteins remove mono-ADP-ribose from in vitro-modified ARTD10 and histone proteins, as well as from PARGtreated ARTD1, although to a lesser extent. These different susceptibilities to macrodomain-mediated hydrolysis imply that ARTD1 and ARTD10 modify, at least in part, different residues. One study has proposed a C1 linkage of the ADP-ribose to the glutamic acid acceptor residue (99) , whereas a second model points to C2 (68) , but the final proof for either of these possibilities has not been made. To finally answer the question, which C-atom of the distal ribose is attached to the glutamic acid, subsequently hydrolyzed by macrodomains, requires further investigations. However, with these findings, a major gap in understanding glutamic acid-modified ADP-ribose metabolism could be closed. The identification of new ADP-ribosyl hydrolases not only completes the ADP-ribosylation cycle, but also reveals important, biologically and medically relevant regulatory functions of cellular ADP-ribosylation (100). Along this line, MacroD2 could revert the inhibitory ADP-ribosylation of the disease-relevant kinase GSK3ß and thereby restore its activity in vitro and in cells (68) . Furthermore, a deficiency in C6orf130 leads to neurodegenerative diseases (101). The observed defects in patients could be linked to enzymatic mutants of C6orf130 and thus also underline the importance of mono-ADP-ribosyl hydrolysis in humans. Based on the ability of C6orf130 to remove the intact PARchain from ARTD1, C6orf130 was named terminal ADPribose protein glycohydrolase (TARG1) (101) . As this finding could not be reproduced yet, the existence of a TARG has to be further investigated (79) (and own observations). Moreover, it remains to be clarified, whether other acceptor residues, such as lysine, or asparagine, are irreversibly modified or whether other, yet unidentified enzymes erase these modifications (Figure 2b ).
TOWARDS IDENTIFYING THE ADP-RIBOSYLOME
The tools to study ADP-ribosylation are currently very limited. Especially the lack of suitable antibodies for mono-ADP-ribosylation or for site-specific modifications restricts the analysis of ADP-ribosylation in complex biological systems. Until now, most studies that have identified ADP-ribosylated proteins and their ADP-ribose acceptor sites were performed in a targeted manner, analyzing only a few candidate proteins. It is therefore of great importance to establish new methods for the analysis of ADP-ribosylated proteins and for the identification of their modification acceptor sites. Advances in proteomics technologies, especially in mass spectrometry (MS), and the use of ADP-ribose readers as tools to purify or enrich ADP-ribosylated proteins, has recently opened exciting possibilities to study this complex protein modification. These systemic studies have broadened our horizon on the extent of the ADP-ribosylome and of ADP-ribosylation in the cell.
Identification of ADP-ribosylated proteins by protein microarrays
Protein microarrays are a powerful option to study protein interactions and modifications on a large scale and have been already successfully applied for the identification of kinase substrates (102) . Recently, two studies have employed ProtoArrays®, covering around 8'000 proteins immobilized on glass slides to identify target proteins for ARTD2, ARTD8 and ARTD10 (103, 104) . In both cases, recombinant ARTDs were used to modify the spotted proteins in vitro with biotinylated-NAD + and modified proteins were subsequently visualized by fluorescence-labeling of the biotin moiety in ADPribose. Of the 8'000 spotted proteins, 51 were ARTD2 substrates, 142 were ARTD8 substrates and 78 proteins were modified by ARTD10. Among the identified proteins were targets already known, confirming the applicability of protein microarrays for ADP-ribosylation target identification. As protein microarrays are only applicable for in vitro approaches, alternative techniques are key to obtain further insights into cellular ADP-ribosylation.
Enrichment strategies for ADP-ribosylated proteins
Since the fraction of cellular proteins with a particular modification is usually very small, researchers commonly use antibodies or other enrichment strategies specific for certain PTMs. This reduces the complexity of the cell lysate required for the subsequent identification of the proteins and their modification sites by mass spectrometry. A prominent example is the well-studied phospho-proteome (105, 106) . Due to the availability of only one antibody against PAR and the lack of good antibodies against mono-ADP-ribosylated proteins, alternative methods for the identification of ADPribosylated proteins had to be established. Up to now, several studies attempted to identify the cellular 'ADPribosylome' by employing different methods.
In an elegant study the clickable NAD + analog 6-alkyne-NAD was used for the identification of ARTD1 substrate proteins (107) . ARTD1 knockdown lysates were supplemented with ARTD1 and 6 -alkyne-NAD, which subsequently was conjugated to Biotin-N3 in a click chemistry reaction. The modified proteins could then be purified with streptavidin and analyzed by mass spectrometry. This assay identified over 70 proteins, with a partial overlap to the study described earlier. However, since the NAD analogue is spiked into a lysate, which no longer contains cellular compartments and does not resemble the natural state of the cell, the results might be prone to the identification of false positive hits.
An important method for the enrichment of ADPribosylated proteins is the use of immobilized boronate derivatives (108, 109) . Boronic acid groups form covalent esters with cis-diol groups that are present in various sugars and can therefore be used for the enrichment and monitoring of sugar-containing compounds (110, 111) . Many decades ago, boronic acid-based enrichment led to the identification of the first ADP-ribosylated histones from cells (108, 109) . Recently, the use of boronic acid was reintroduced into the ADP-ribosylation field by its successful application for the enrichment and mass spectrometric analysis of glycated proteins (112) (113) (114) . In contrast to other enrichment strategies, boronic acid does not discriminate between mono-and poly-ADP-ribosylated proteins (108) and can therefore be applied to analyze the whole population of ADP-ribosylated proteins. Nevertheless, different drawbacks complicate the use of boronic acid enrichment. In particular, different derivatives and immobilizations can lead to varying specificities for different sugars and to differences in the pH-dependency of the binding reaction (115, 116) .
Antibody-based enrichment protocols suffer from the lack of antibodies for mono-ADP-ribosylation. However, a study has employed the monoclonal PARbinding antibody 10H (117) to enrich poly-ADPribosylated proteins from cellular extracts (43) . To increase the amount of ADP-ribosylated proteins, PARG knockdown cells were treated with 100 µM N-methyl-N'-nitro-N'-nitroso-guanidine (MNNG) to induce genotoxic stress.
Modified proteins were enriched by immunoprecipitation using the 10H antibody, under conditions still allowing indirect complex formations, and afterwards separated by SDS-PAGE. This procedure led to the identification of over 300 PAR-associated proteins with various cellular functions. The majority consisted of proteins involved in the DNA damage response, DNA and RNA metabolism and regulation, as well as cell death and cell cycle regulation (43) . This study tremendously increased the number of identified PAR interacting proteins, but unfortunately could not fully distinguish between poly-ADP-ribosylated proteins and proteins that are forming a complex with modified proteins. Furthermore, mono-ADP-ribosylated proteins could not be identified due to the fact that the 10H antibody only binds to poly-and not oligo-and mono-ADP-ribose modifications (117) .
An alternative method for the enrichment of ADP-ribosylated proteins is the use of the abovementioned, ADP-ribose-binding macrodomain Af1521 (118, 119) . In an initial study, modified proteins were enriched with Af1521, separated by SDS-PAGE, and identified by mass spectrometry (120) . To reduce background, a non-binding mutant of Af1521 was used in a pre-clearing step. This method led to the identification of ADP-ribosylated proteins, including previously known targets such as ARTD1, Elongation factor-1-a and GDH1. However, the fact that the binding occurred under native conditions allowed also an indirect enrichment of proteins interacting with PARylated proteins. More recently, the same method was used in combination with stable isotope labeling by amino acids in cell culture (SILAC) and mass spectrometry (119).
Mass spectrometry techniques for ADP-ribosylation research
Today, the identification and characterization of PTMs is facilitated by mass spectrometry and a vast amount of information about various modifications and their functions is available because of these techniques (121, 122) . Prominent examples are phosphorylation, ubiquitination and glycosylation, where great advances were made in the recent years (123) (124) (125) . Therefore, also the field of ADP-ribosylation is in need for novel protocols and methods to enter this exciting development and to gain a broader insight into the dynamics of ADP-ribosylation.
Earlier studies on ADP-ribosylated substrates concluded that the site identification with state-of-the-art mass spectrometry techniques at that time was not possible (126) . Furthermore, detailed studies on the fragmentation behavior of ADP-ribose and modified peptides revealed that the modification is almost completely fragmented under conventional MS conditions using collision-induced dissociation (CID) (127) . Although the fragmentation profile always generated the same fragments, with ions indicative for ADP-ribosylated peptides, the fragmentation of the peptide backbone by CID was too weak to gain enough information of the peptide sequence and to allow for the determination of the modification site. Furthermore, in most cases ADP-ribose is completely fragmented by CID fragmentation and no rest remains on the amino acid. Therefore, identification of the acceptor site within an ADP-ribosylated peptide by CID-MS has remained challenging.
Recently, novel fragmentation techniques for the identification of ADP-ribosylated peptides by MS have been established. Electron capture dissociation (ECD) is a non-ergonic process, leading to a high proportion of random peptide backbone cleavages during fragmentation (128) . This process is especially suited for highly charged peptides, since it leads to the stabilization of labile PTMs on the peptide and to a better c and z ion series, which allows better sequence assignments (129) . When ECD was applied to a chemically ADP-ribosylated standard peptide containing only arginine as a potential acceptor, the modification as well as its site could be readily annotated, underlining the power of this method (127) . A second fragmentation method that uses a comparable chemistry to ECD is electron transfer dissociation (ETD). The advantage of ETD is its better availability and accessibility due to lower machine costs (130) . ETD has also been successfully applied to chemically ADP-ribosylated peptides and more complex protein mixtures and enabled the identification of modified arginine as well as lysine residues (131, 132). The first study that used ETD to detect ADP-ribosylation sites on histones enzymatically modified by ARTD1 in vitro, identified lysine residues as acceptors and thereby showed the robustness of the ETD approach (133) .
A third fragmentation technique that was recently introduced is higher energy collisional dissociation (HCD) (119, 134) . In comparison to CID, the advantage of HCD is a better coverage of the whole mass range and the ability to acquire MS and MS/MS spectra at high resolution, thereby recording smaller fragment ions, which leads to better sequence and PTM assignment (135, 136) . HCD thus seems to be a promising fragmentation technique for ADP-ribosylation studies.
6.4.Detection of ADP-ribosylated peptides from in vitro modified proteins by mass spectrometry
As PAR is very complex due to its length and branched structure, the detection of PARylated peptides by MS/MS is very challenging. To overcome this drawback, the complexity of PAR can be reduced in vitro by different methods. The pre-treatment of the samples with PARG reduces the modification to one protein-bound ADP-ribose moiety (see above). An alternative option is the enzymatic reduction of PAR by cleaving the pyrophosphate bond of ADP-ribose by phosphodiesterase 1 (PDE1) in vitro. This reaction reduces the complexity of the modification and turns it into a chemically more stable group (i.e., phosphoribose). The newly formed terminal phosphate group can be used to enrich modified peptides with conventional phosphopeptide enrichment strategies. A recent study identified several glutamic acid as well as lysine residues in ARTD1 as potential acceptors; however, the unambiguous annotation of the exact modification site was not possible due to a lack of sequence information in the CID spectra (137) . An additional approach reduced the complexity of PARylation by using a mutated ARTD1 carrying an E to Q mutation at position 988, which hinders PAR formation, making ARTD1 E988Q an inefficient mono-ADPribosyltransferase (138, 139) . With this approach, D387, E488 and E491 within the automodification domain of the ARTD1 E988Q mutant could be identified as auto-ADPribosylation sites by CID mass spectrometry (140) . However, it remains to be clarified, whether mutating important amino acids of the catalytic domain of ARTDs is not changing the specificity of the catalytic reaction.
Identification of the ADP-ribosylome by mass spectrometry
In a more global analysis, the above-introduced Af1521-based enrichment method was utilized to identify the ADP-ribosylome from cells that underwent different types of genotoxic stress (119) . The use of H 2 O 2 , MMS, UV-irradiation and ionizing irradiation identified a total of 235 stress-induced ADP-ribosylated proteins, but not their ADP-ribose acceptor sites. The i dentified proteins are mainly localized in the nucleus and involve numerous previously identified targets. The identified target proteins could furthermore be functionally sorted into two main groups: the well established group of proteins involved in DNA metabolism, involving players of the DNA repair, DNA replication as well as chromosome organization and proteins involved in RNA metabolism features like transcription, processing and splicing of RNA. In contrast to DNA damage, RNA metabolism was so far not as extensively l inked to ADP-ribosylation, therefore, these results open new and interesting possibilities in the field of ADP-ribosylation research.
A second global dataset of ADP-ribosylated peptides and their modification sites was generated with a novel combination of enrichment and chemical disruption of the ADP-ribose (141) . ADP-ribosylated peptides were enriched by boronate affinity chromatography, in which boronic acid groups covalently bind 1,2-cis-diols that are present in sugars, allowing for the enrichment of ADPribosylated peptides (112, 142) . As the ester bonds between the ADP-ribose and the acceptor amino acids glutamate and aspartate are labile in the presence of NH 2 OH (143), peptides modified at these residues could be eluted by adding NH 2 OH. Interestingly, not the whole modification is removed, but a 15 Da mass shift is detected, allowing the determination of the ADP-ribosylation site within the enriched peptides. Even though limited to glutamic-and aspartic acid residues, this study provides 1048 ADP-ribosylation sites from 340 proteins that cover also various functions in DNA metabolism as well as, for example, mRNA processing.
As ADP-ribosylation is very transient and difficult to detect, both studies (119, 141) mentioned above made use of siPARG or shPARG cell lines to boost the cellular ADP-ribosylation signal during the different stimulations. So far, the impact of PARG depletion on the cellular system has not been evaluated, but influences must be expected (e.g., different protein interactions due to hyper-ADP-ribosylation). Moreover, comparison of the two above-mentioned studies revealed that only a part of the modified peptides identified are the same, raising the question, whether the ADP-ribosylome is cell-type specific or whether the preparation influences the outcome. Moreover, it is very likely, that the two methods discussed have different affinities for mono-and poly-ADPribosylated proteins, and as a result, different subsets of the ADP-ribosylome have been identified. Therefore, improved and novel tools, as well as further extensive studies will be required to address the cellular ADP-ribosylome.
PERSPECTIVE
The research on the ADP-ribosylome so far clearly shows that different classes of amino acids on a broad variety of target proteins are ADP-ribosylated. Furthermore, depending on the analyzed conditions, modifications can comprise single ADP-ribose moieties or PAR chains of various lengths and branching patterns. Due to this huge complexity in acceptor proteins, modification sites, linkage types and ADP-ribose structures, it is highly unlikely that one method alone will be able to reliably detect all ADP-ribosylated proteins in a given sample, e.g. a cell lysate. In the future, more large-scale systematic studies and new approaches are needed to build a comprehensive database of all ADP-ribose modifications. It would be highly advantageous if the research community agreed on a limited number of cell types to allow comparison of the results obtained by different methods and under different experimental conditions.
Identification of a conserved ADP-ribosylation motif
A comprehensive database of identified and confirmed ADP-ribose acceptor sites will not only serve as a foundation for in-depth analyses of the cellular function of ADP-ribose modification, but may also allow the identification of a consensus sequence for ADPribosylation sites. Such an ADP-ribosylation motif could become an important tool to predict all potential ADPribosylation sites in different organisms and cells.
Functional contribution of the ARTD family members
One of the most challenging future tasks is the assignment of all ADP-ribose modifications (i.e., proteins and acceptor sites) to specific ARTD family members. Based on our current understanding, it is to be expected that the substrate specificities of the different ARTDs considerably overlap. Deletion or knockdown studies may therefore not be able to reveal the substrate spectrum of all ARTDs. To define which proteins are modified by each individual ARTD family member, in vitro experiments with recombinantly expressed ARTD proteins therefore seem to be the most promising approach. The results from such studies will help to predict the cellular contribution and function of all ARTD members, and therefore constitute the foundation for their detailed and comprehensive analysis in vivo.
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